3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
2
Breast Neoplasms
2
Thymus Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Prostatic Neoplasms
1
Mesothelioma
1
Melanoma
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
enzalutamide
92
Magnetic Resonance Spectroscopy
87
Specimen Handling
66
Prednisone
65
Androgen Antagonists
59
Abiraterone Acetate
59
apalutamide
56
Radiosurgery
53
Radiotherapy
47
Leuprolide
47
darolutamide
46
abiraterone
44
Docetaxel
43
Radiation
31
Pluvicto
31
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
30
Biopsy
30
relugolix
28
Surveys and Questionnaires
28
pembrolizumab
26
gallium 68 PSMA-11
26
Standard of Care
26
Triptorelin Pamoate
25
Goserelin
25
bicalutamide
23
Gonadotropin-Releasing Hormone
23
Brachytherapy
21
Carboplatin
20
X-Rays
19
luprolide acetate gel depot
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Histocompatibility Testing
×
1 year
×
Clear all
NCT05577689
2025-06-05
NTTPro
Fudan University
Recruiting
100 enrolled